Chronic Beryllium Disease: A Hypersensitivity Disorder

Applied Occupational and Environmental Hygiene

Volumn 16, Issue 5, 2001, Pages 615-618

  Rossman, Milton D ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beryllium; Beryllium Lymphocyte Proliferation Test; Bronchoalveolar Lavage

Indexed keywords

BERYLLIUM; GLUTAMINE;

ALLELE; ANTIGEN PRESENTING CELL; ARTICLE; BERYLLIOSIS; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FIBEROPTIC BRONCHOSCOPY; GRANULOMATOSIS; HYPERSENSITIVITY; IMMUNITY; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; PRIORITY JOURNAL; SKIN TEST;

BERYLLIOSIS; GRANULOMA; HLA-D ANTIGENS; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE ACTIVATION;

EID: 0035016715     PISSN: 1047322X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10473220121477     Document Type: Article

References (17)

1. Van Ordstrand, H.S.; Hughes, R.; Carmody, M.G.: Chemical Pneumonia in Workers Extracting Beryllium Oxide: Report of Three Cases. Cleveland Clinic J Med, 10:10–18 (1943).
2. Hardy, H.L.; Tabershaw, I.R.: Delayed Chemical Pneumonitis Occuring inWorkers exposed to Beryllium Compounds. J Indus Hyg Toxicol 28:197–211 (1946).
3. Aronchick, J.M.; Rossman, M.D.; Miller, W.T.: Chronic Beryllium Disease: Diagnosis, Radiographic Findings, and Correlation with Pulmonary Function Tests. Radiology 163:677–682 (1987).
4. Sprince, N.L.; Kazemi, H.: U.S. Beryllium Case Registry Through 1977. Environ Res 21:44–47 (1980).
5. Eisenbud, M.; Lisson, J.: Epidemiological Aspects of Beryllium-Induced Nonmalignant Lung Disease: A 30-Year Update. J Occup Med 25:196–202 (1983).
6. Sterner, J.H.; Eisenbud, M.: Epidemiology of Beryllium Intoxication. Arch Indus Hyg Occup Med 3:123–151 (1951).
7. Curtis, G.H.: The Diagnosis of Beryllium Disease, with Special Reference to the Patch Test. Arch of Indus Health 19:150–153 (1959).
8. Hani n, J.M.; Epstein, W L.; Cline, M.J.: InVitro Studies ofGranulomatous Hypersensitivity to Beryllium. J Invest Derm55:284–288 (1970).
9. Waksman, B.H.: The Diagnosis of Beryllium Disease, with Special Reference to the Patch test. Arch Indus Health 19:154–156 (1959).
10. Deodhar, S.D.; Barna, B.; Van Ordstrand, H.S.: A Study of the Immunologic Aspects of Chronic Berylliosis. Chest 63:309–313 (1973).
11. Epstein, P.E.; Dauber, J.H.; Rossman, M.D. et al.: Bronchoalveolar Lavage in a Patient with Chronic Berylliosis: Evidence for Hypersensitivity Pneumonitis. Ann Intern Med 97:213–219 (1982).
12. Rossman, M.D. et al.: Proliferative Response of Bronchoalveolar Lymphocytes to Beryllium: A Test for Chronic Beryllium Disease. Ann Intern Med 108:687–693 (1988).
13. Saltini, C. et al.: Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Speci. c Helper T Cells. New Eng J Med 320:1103–1109 (1989).
14. Richeldi, L.; Sorrentino, R.; Saltini, C.: HLA-DPB1 Glutamate 69: A Genetic Marker of Beryllium Disease. Science 262:242–244 (1993).
15. Stubbs, J. et al.: Genetic Markers in Beryllium Hypersensitivity. Chest 109:45s (1996).
16. Richeldi, L. et al.: Interaction of Genetic and Exposure Factors in the Prevalence of Berylliosis. Amer J Indus Med 32:337–340 (1997).
17. Wang, Z. et al.: Differential Susceptibilities to Chronic Beryllium Disease Contributed by Different glu69 HLA-DPB1 and -DPA1 Alleles. J Immun 163:1647–1653 (1999).